期刊
ADVANCES IN CHRONIC KIDNEY DISEASE
卷 29, 期 3, 页码 231-242出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ackd.2022.04.003
关键词
Atypical hemolytic uremic syndrome; C3 glomerulopathy; Transition; Education; Transplantation
Transition of clinical care of pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis to adult nephrologists poses challenges. Raising awareness, providing education, and establishing ongoing dialogue are crucial for optimal patient outcomes and safe transition to adulthood.
Atypical hemolytic uremic syndrome and C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis are ultra-rare chronic, complement-mediated diseases with childhood manifestation in a majority of cases. Transition of clinical care of patients from pediatric to adult nephrologists-typically with controlled disease in native or transplant kidneys in case of atypical hemolytic uremic syndrome and often with chronic progressive disease despite treatment efforts in case of C3 glomerulopathy/immune complex membranoproliferative glomerulonephritis-identifies a challenging juncture in the journey of these patients. Raising awareness for the vulnerability of this patient cohort; providing education on disease path-ophysiology and management including the use of new, high-precision complement antagonists; and establishing an ongoing dialog of patients, families, and all members of the health care team involved on either side of the age divide will be inevitable to ensure optimal patient outcomes and a safe transition of these patients to adulthood.(c) 2022 by the National Kidney Foundation, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据